Very low impurity Hydroxypropyl Betacyclodextrin (KLEPTOSE HPB-LB) complying with Chinese Pharmacopoeia from Roquette to Resolve Formulation Challenges Read more
Cipla continues to expand focus on therapy areas of promising growth through deals: GlobalData Read more
Future proofing of work function will be defined by a maturity model across three elements: IPA-BCG Read more